DBYAN Medicine Professional Corporation Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2015
NCT02792803
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

apo-latanoprost (1 trial)

co-latanoprost (1 trial)

latanoprost (xalatan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glaucoma (Phase 4)

Glaucoma, Open-Angle (Phase 4)

Hypertension (Phase 4)

Ocular Hypertension (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3